|
SKA1 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.696200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.986800E-01 |
| Normal-vs-Stage2 |
2.175400E-01 |
| Normal-vs-Stage3 |
8.311800E-01 |
| Normal-vs-Stage4 |
8.320200E-01 |
| Stage1-vs-Stage2 |
1.780080E-03 |
| Stage1-vs-Stage3 |
6.198000E-01 |
| Stage1-vs-Stage4 |
6.948800E-01 |
| Stage2-vs-Stage3 |
3.747700E-02 |
| Stage2-vs-Stage4 |
1.594290E-02 |
| Stage3-vs-Stage4 |
4.896200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.814600E-01 |
| Normal-vs-AfricanAmerican |
5.647800E-01 |
| Normal-vs-Asian |
9.958800E-01 |
| Caucasian-vs-AfricanAmerican |
3.877000E-01 |
| Caucasian-vs-Asian |
9.707000E-01 |
| AfricanAmerican-vs-Asian |
3.715000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.962200E-01 |
| Normal-vs-Female |
8.217800E-01 |
| Male-vs-Female |
5.588600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.947200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.154000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.184000E-01 |
| Normal-vs-Age(81-100Yrs) |
1.924030E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.386240E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.383800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.328400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.283900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.913700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.710000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.414000E-01 |
| Classical-VS-Follicular |
4.024600E-03 |
| Classical-VS-Other |
1.919820E-01 |
| Classical-VS-Normal |
8.819200E-01 |
| Tall-VS-Follicular |
1.249830E-01 |
| Tall-VS-Other |
4.797600E-01 |
| Tall-VS-Normal |
9.392200E-01 |
| Follicular-VS-Other |
4.447800E-01 |
| Follicular-VS-Normal |
2.686400E-01 |
| Other-VS-Normal |
5.572200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.784800E-01 |
| Normal-vs-N1 |
7.862600E-01 |
| N0-vs-N1 |
9.971600E-01 |
|
|
